Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade® (Infliximab)
Crossref DOI link: https://doi.org/10.1007/s12325-016-0403-9
Published Online: 2016-09-01
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Derzi, Mazin
Johnson, Theodore R.
Shoieb, Ahmed M.
Conlon, Hugh D.
Sharpe, Penny
Saati, Andrew
Koob, Sarah
Bolt, Michael W.
Lorello, Leslie G.
McNally, Jim
Kirchhoff, Carol F.
Smolarek, Teresa A.
Leach, Michael W.
Funding for this research was provided by:
Pfizer